### [2014-07-2](/news/2014/07/2/index.md)

# Roche Holding AG says that its US-based Genentech subsidiary will purchase American biotechnology company Seragon Pharmaceuticals, Inc for up to $1.725 billion in cash and contingency payments. 




### Source:

1. [AP](http://hosted.ap.org/dynamic/stories/E/EU_SWITZERLAND_ROCHE_SERAGON?SITE=AP&SECTION=HOME&TEMPLATE=DEFAULT)

### Related:

1. [The U.S. Justice Department announces pharmaceutical companies Genentech Inc. and  OSI Pharmaceuticals Inc. will pay $67 million to settle False Claims Act allegations for misleading statements about the effectiveness of the drug Tarceva in treating non-small-cell lung carcinoma. ](/news/2016/06/7/the-u-s-justice-department-announces-pharmaceutical-companies-genentech-inc-and-osi-pharmaceuticals-inc-will-pay-67-million-to-settle-f.md) _Context: Genentech Inc._
2. [ Connecticut. A former hedge fund manager, Scott Sacane, pleaded guilty to one count of violating the Investment Advisers Act of 1940 in connection with the manipulation of the prices of two biotechnology stocks between November 2002 and July 2003. [http://www.stamfordadvocate.com/business/scn-sa-durus2dec22,0,2036231.story?coll=stam-business-headlines (Stamford (CT) Advocate)] (Link dead as of 00:49, 15 January 2007 (UTC))](/news/2005/12/21/connecticut-a-former-hedge-fund-manager-scott-sacane-pleaded-guilty-to-one-count-of-violating-the-investment-advisers-act-of-1940-in-con.md) _Context: biotechnology_
